Literature DB >> 29258926

No treatment-related effects with aryloxyalkanoate dioxygenase-12 in three 28-day mouse toxicity studies.

Sabitha Papineni1, Johnson Thomas2, Valerie A Marshall3, Daland R Juberg4, Rod A Herman5.   

Abstract

The aryloxyalkanoate dioxygenase-12 (AAD-12) protein is expressed in genetically modified soybean events DAS-68416-4 and DAS-444Ø6-6. Expression of the AAD-12 protein in soybeans confers tolerance to the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) providing an additional herbicide choice to farmers. This enzyme acts by catalyzing the degradation of 2,4-D into herbicidally inactive metabolites. To meet evolving interpretation of regulations in the European Union, three separate 28-day repeat-dose oral mouse studies were conducted at increasing doses of up to 1100 mg AAD-12 protein/kg bw/day. No treatment-related effects were seen in any of these three studies.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  28-Day; AAD-12; Mouse; Toxicology

Mesh:

Substances:

Year:  2017        PMID: 29258926     DOI: 10.1016/j.yrtph.2017.12.012

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  1 in total

1.  Toxicological evaluation of transgenic silkworms.

Authors:  Liang Jiang; Yumei Wang; Huizhen Guo; Qiang Sun; Enyu Xie; Haoyu Liuli; Qing Li; Qingyou Xia
Journal:  Toxicol Res (Camb)       Date:  2020-12-18       Impact factor: 3.524

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.